Peri‐operative drug prescribing pattern and manufacturers' guidelines: An audit

M. T. Kluger, S. Gale, J. L. Plummer, H. Owen

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Many patients admitted for surgery are receiving regular drug therapy. Adverse effects may occur, either as a result of these drugs being stopped suddenly or because staff are unaware of significant interactions between certain drugs and anaesthetic agents or techniques. This study aimed to find out how regular drug medication is actually given in the peri‐operative period. In addition, pharmaceutical companies were contacted and asked for information about the effects of sudden withdrawal of their products and potential interactions with anaesthetic agents. We found that many drugs were omitted peri‐operatively with potentially significant effects. Pharmaceutical companies do not seem to appreciate the importance of this problem and not all of them give clear recommendations relevant to practising anaesthetists.

Original languageEnglish
Pages (from-to)456-459
Number of pages4
JournalAnaesthesia
Volume46
Issue number6
DOIs
Publication statusPublished - Jun 1991
Externally publishedYes

Keywords

  • anaesthetics
  • Complications
  • drug
  • Interactions
  • peri‐operative medication
  • peri‐operative period
  • Surgery

Fingerprint Dive into the research topics of 'Peri‐operative drug prescribing pattern and manufacturers' guidelines: An audit'. Together they form a unique fingerprint.

  • Cite this